Cancercare Launches New Program to Help Multiple Myeloma Patients Cover Transportation Costs
Last Updated on Tuesday, 25 August 2009 03:27 Tuesday, 25 August 2009 03:20
Myeloma Forums - Myeloma Forums

"Door to Door" initiative offers individual grants to patients to help defray transportation costs to and from medical care.
New York, NY, July 20, 2009— CancerCare announced today the launch of the "Door to Door" program for patients with multiple myeloma. CancerCare's program will provide individual grants of up to $600 annually to multiple myeloma patients for covering transportation costs such as gasoline, parking and tolls, and taxi, bus or train fare to and from their medical care.
The program is funded in part by a generous grant from Millennium: The Takeda Oncology Company. CancerCare is a national non-profit organization based in New York City that provides free support services to people affected by cancer.
Multiple myeloma is a cancer of the bone marrow that is diagnosed in approximately 20,000 people annually in the U.S. Advances in the treatment of this cancer have dramatically increased patients' life expectancy (an estimated 60,000 people in the U.S. are now living with multiple myeloma) and consequently lengthened the duration of treatment.
"Because of the nature of their therapies and the disease itself, many multiple myeloma patients may be required to visit their doctors several times a week over many months. Particularly for patients on a fixed income, these travel expenses add up and create a financial burden that may prevent them from keeping up with their health care," noted Diane Blum, executive director of CancerCare. "The Door to Door program will provide much-needed relief to this patient population, and we are grateful for Millennium's support."
Founded in 1944, CancerCare has a long track record of providing financial assistance to people facing cancer; it is a cornerstone of its direct support services to help people cope with the emotional and practical issues of a cancer diagnosis. During fiscal year 2009, CancerCare provided over $4.2 million in grants to more than 24,000 people with cancer to cover treatment-related costs like transportation, child care and medications for side effects.
Last year CancerCare launched a separate foundation to help cancer patients cover the cost of their health insurance co-payments for certain types of treatments. To date, the CancerCare Co-Payment Assistance Foundation has assisted thousands of people undergoing cancer treatments with grants of up to $10,000.
To receive a Door to Door transportation grant, patients must meet certain eligibility criteria and complete an application form. A sample patient application form along with a physician verification form may be viewed online. To apply, call 1-800-813-HOPE (4673).
For more information about multiple myeloma, read CancerCare's free Connect booklet, Advances in the Treatment of Multiple Myeloma.
| < Prev | Next > |
|---|
Users Online
No users online.
Recent Forum Topics
- 08/24/2010 01:36 Live Cell Therapy at Advanced Medical Group (Wilsons)
- 08/21/2010 03:03 "favorite quotes or sayings" cancer related or not (olivia751)
- 08/08/2010 23:41 blood tests? (jvanderwood)
- 08/08/2010 16:12 blood tests? (charra)
- 08/03/2010 02:33 Live Cell Therapy at Advanced Medical Group (Janiels)
- 07/30/2010 16:20 What is wrong with me possibly? (Rick)
- 07/30/2010 16:13 What is wrong with me possibly? (Rick)
- 07/29/2010 17:23 Hi from Waitakere, NZ (daughter)
- 07/29/2010 15:24 older mom with MM diagnosis, now what (bandm hx)
- 07/29/2010 09:28 Hi from Waitakere, NZ (Supersid)
- 07/28/2010 09:44 Stem Cell Treatment Ukraine - EmCell Clinic (sunshine)
- 07/28/2010 09:40 Effects of Tumeric and Multiple Myeloma (sunshine)
- 07/28/2010 09:36 Motorcycle season (sunshine)
- 07/28/2010 09:34 Hi from B.C. (sunshine)
- 07/28/2010 09:27 Hi from Waitakere, NZ (sunshine)
Tag Cloud
Search Articles
Polls
Polls
Myeloma News
- International study to improve treatments for Duchenne muscular dystrophy launched
- ImmunoCellular Therapeutics Issues Letter to Shareholders
- Celgene receives Paragraph IV Certification Letter on submission of ANDA for REVLIMID
- Cardiogenesis Corporation releases comment on STAR-heart study
- Celgene Officially Notified of ANDA Filing for REVLIMID®
Medworm
- Summer office hours have been extended. The office and hotline will close at 2:00 PM...
- With the help of IMFer Cathy Goetz' testimony, the oral-parity bill has passed in California.
- Jack Aiello named IMF Advocate of the Month!!
- BEAT CANCER TO THE FINISH LINE!Thank you to all IMFers who voted for our entry,...
- BEAT CANCER TO THE FINISH LINE!Thank you to all IMFers who voted for our entry...
- BEAT CANCER TO THE FINISH LINE!We have only a few more days left. Take 30...
- Audio of the Living Well with Myeloma Teleconference on Nutrition is on the web.
- BEAT CANCER TO THE FINISH LINE!Calling all IMFers to raise awareness by casting a vote...
Myeloma Beacon
- Pat’s Place: A Patient’s Reflections On The Progress Of Multiple Myeloma Research
- Guide To Nutrition In Multiple Myeloma – Part 2: Supplements
- Oral Busulfan Treatment May Be More Effective But Not As Safe As Melphalan Prior To...
- NICE Recommends Thalidomide Over Velcade As First Line Treatment For Multiple Myeloma In The U.K.
- Guide To Nutrition In Multiple Myeloma – Part 1: An Introduction
- Pat’s Place: Suggestions To Help Improve A Multiple Myeloma Patient’s Quality Of Life
- Velcade-Dexamethasone Therapy Improves Prognosis Of Multiple Myeloma Patients With The Chromosomal Abnormality t(4;14)
- Personal Perspective: Tips For How Every Myeloma Patient Can Be Their Own Advocate
- Etoposide Is Highly Effective For Stem Cell Mobilization In Multiple Myeloma Patients
- Hycamtin-Cyclophosphamide-Melphalan May Be Effective And Safe For Multiple Myeloma Patients
Archives by month
Visitors Counter







![]() | Today | 631 |
![]() | Yesterday | 1019 |
![]() | This week | 5445 |
![]() | Last week | 6230 |
![]() | This month | 2597 |
![]() | Last Month | 28725 |
![]() | All | 234677 |
Your IP: 38.107.191.82
,
Now is: 2010-09-03 15:10








